Avi Avramoff
Chief Tech/Sci/R&D Officer chez TARO PHARMACEUTICAL INDUSTRIES LTD.
Profil
Avi Avramoff is currently the Vice President & Head of Research & Development at Taro Pharmaceutical Industries Ltd.
Prior to his current position, he served as the Vice President of Research & Development at Dexcel Pharma Technologies Ltd.
from 1994 to 2011.
Postes actifs de Avi Avramoff
| Sociétés | Poste | Début |
|---|---|---|
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Chief Tech/Sci/R&D Officer | 01/10/2011 |
Anciens postes connus de Avi Avramoff
| Sociétés | Poste | Fin |
|---|---|---|
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Chief Tech/Sci/R&D Officer | 01/01/2011 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
